191 related articles for article (PubMed ID: 36768755)
1. Overexpression of Insulin Receptor Substrate 1 (IRS1) Relates to Poor Prognosis and Promotes Proliferation, Stemness, Migration, and Oxidative Stress Resistance in Cholangiocarcinoma.
Kaewlert W; Sakonsinsiri C; Lert-Itthiporn W; Ungarreevittaya P; Pairojkul C; Pinlaor S; Murata M; Thanan R
Int J Mol Sci; 2023 Jan; 24(3):. PubMed ID: 36768755
[TBL] [Abstract][Full Text] [Related]
2. Prolonged oxidative stress down-regulates Early B cell factor 1 with inhibition of its tumor suppressive function against cholangiocarcinoma genesis.
Armartmuntree N; Murata M; Techasen A; Yongvanit P; Loilome W; Namwat N; Pairojkul C; Sakonsinsiri C; Pinlaor S; Thanan R
Redox Biol; 2018 Apr; 14():637-644. PubMed ID: 29169115
[TBL] [Abstract][Full Text] [Related]
3. Roles of Zinc Finger Protein 423 in Proliferation and Invasion of Cholangiocarcinoma through Oxidative Stress.
Chaiprasert T; Armartmuntree N; Techasen A; Sakonsinsiri C; Pinlaor S; Ungarreevittaya P; Khuntikeo N; Namwat N; Thanan R
Biomolecules; 2019 Jul; 9(7):. PubMed ID: 31284679
[TBL] [Abstract][Full Text] [Related]
4. Development and characterization of a hydrogen peroxide-resistant cholangiocyte cell line: A novel model of oxidative stress-related cholangiocarcinoma genesis.
Thanan R; Techasen A; Hou B; Jamnongkan W; Armartmuntree N; Yongvanit P; Murata M
Biochem Biophys Res Commun; 2015 Aug; 464(1):182-8. PubMed ID: 26100205
[TBL] [Abstract][Full Text] [Related]
5. Adaptor protein XB130 regulates the aggressiveness of cholangiocarcinoma.
Poosekeaw P; Pairojkul C; Sripa B; Sa Ngiamwibool P; Iamsaard S; Sakonsinsiri C; Thanan R; Ungarreevittaya P
PLoS One; 2021; 16(11):e0259075. PubMed ID: 34780466
[TBL] [Abstract][Full Text] [Related]
6. Increase in L-type amino acid transporter 1 expression during cholangiocarcinogenesis caused by liver fluke infection and its prognostic significance.
Yothaisong S; Namwat N; Yongvanit P; Khuntikeo N; Puapairoj A; Jutabha P; Anzai N; Tassaneeyakul W; Tangsucharit P; Loilome W
Parasitol Int; 2017 Aug; 66(4):471-478. PubMed ID: 26657242
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of microRNA-205-5p promotes cholangiocarcinoma growth by reducing expression of homeodomain-interacting protein kinase 3.
Mon AM; Intuyod K; Klungsaeng S; Jusakul A; Pongking T; Lert-Itthiporn W; Luvira V; Pairojkul C; Plengsuriyakarn T; Na-Bangchang K; Pinlaor S; Pinlaor P
Sci Rep; 2023 Dec; 13(1):22444. PubMed ID: 38105269
[TBL] [Abstract][Full Text] [Related]
8. Lactic acidosis promotes aggressive features of cholangiocarcinoma cells via upregulating ALDH1A3 expression through EGFR axis.
Thamrongwaranggoon U; Detarya M; Seubwai W; Saengboonmee C; Hino S; Koga T; Nakao M; Wongkham S
Life Sci; 2022 Aug; 302():120648. PubMed ID: 35598658
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of TTYH3 promotes epithelial-to-mesenchymal transition through Wnt/β-catenin signaling and inhibits apoptosis in cholangiocarcinoma.
Xue W; Dong B; Zhao Y; Wang Y; Yang C; Xie Y; Niu Z; Zhu C
Cell Oncol (Dordr); 2021 Dec; 44(6):1351-1361. PubMed ID: 34796468
[TBL] [Abstract][Full Text] [Related]
10. Annexin A1 Is a Potential Prognostic Marker for, and Enhances the Metastasis of, Cholangiocarcinoma.
Kotepui KU; Obchoei S; Vaeteewoottacharn K; Okada S; Wongkham S; Sawanyawisuth K
Asian Pac J Cancer Prev; 2022 Feb; 23(2):715-721. PubMed ID: 35225485
[TBL] [Abstract][Full Text] [Related]
11. Annexin A1: A new immunohistological marker of cholangiocarcinoma.
Hongsrichan N; Rucksaken R; Chamgramol Y; Pinlaor P; Techasen A; Yongvanit P; Khuntikeo N; Pairojkul C; Pinlaor S
World J Gastroenterol; 2013 Apr; 19(16):2456-65. PubMed ID: 23674846
[TBL] [Abstract][Full Text] [Related]
12. YY1-induced DLEU1/miR-149-5p Promotes Malignant Biological Behavior of Cholangiocarcinoma through Upregulating YAP1/TEAD2/SOX2.
Li J; Jiang X; Xu Y; Kang P; Huang P; Meng N; Wang H; Zheng W; Wang H; Wang Z; Zhong X; Cui Y
Int J Biol Sci; 2022; 18(11):4301-4315. PubMed ID: 35864972
[TBL] [Abstract][Full Text] [Related]
13. Gankyrin promotes tumor growth and metastasis through activation of IL-6/STAT3 signaling in human cholangiocarcinoma.
Zheng T; Hong X; Wang J; Pei T; Liang Y; Yin D; Song R; Song X; Lu Z; Qi S; Liu J; Sun B; Xie C; Pan S; Li Y; Luo X; Li S; Fang X; Bhatta N; Jiang H; Liu L
Hepatology; 2014 Mar; 59(3):935-46. PubMed ID: 24037855
[TBL] [Abstract][Full Text] [Related]
14. Aberrant expression of GATA binding protein 6 correlates with poor prognosis and promotes metastasis in cholangiocarcinoma.
Tian F; Li D; Chen J; Liu W; Cai L; Li J; Jiang P; Liu Z; Zhao X; Guo F; Li X; Wang S
Eur J Cancer; 2013 May; 49(7):1771-80. PubMed ID: 23313142
[TBL] [Abstract][Full Text] [Related]
15. MCM2 promotes the proliferation, migration and invasion of cholangiocarcinoma cells by reducing the p53 signaling pathway.
Wang CL; Liu XY; Wang YH; Zhang Z; Wang ZD; Zhou GQ
Yi Chuan; 2022 Mar; 44(3):230-244. PubMed ID: 35307646
[TBL] [Abstract][Full Text] [Related]
16. Increased activation of PI3K/AKT signaling pathway is associated with cholangiocarcinoma metastasis and PI3K/mTOR inhibition presents a possible therapeutic strategy.
Yothaisong S; Dokduang H; Techasen A; Namwat N; Yongvanit P; Bhudhisawasdi V; Puapairoj A; Riggins GJ; Loilome W
Tumour Biol; 2013 Dec; 34(6):3637-48. PubMed ID: 23832540
[TBL] [Abstract][Full Text] [Related]
17. Knockdown of tripartite motif 59 (TRIM59) inhibits proliferation in cholangiocarcinoma via the PI3K/AKT/mTOR signalling pathway.
Shen H; Zhang J; Zhang Y; Feng Q; Wang H; Li G; Jiang W; Li X
Gene; 2019 May; 698():50-60. PubMed ID: 30822475
[TBL] [Abstract][Full Text] [Related]
18. NUF2 Drives Cholangiocarcinoma Progression and Migration via Inhibiting Autophagic Degradation of TFR1.
Shan J; Jiang W; Chang J; Zhou T; Chen Y; Zhang Y; Wang J; Wang Y; Wang Y; Xu X; Liu S; Shi X; Fan S; Chen R; Li C; Li X
Int J Biol Sci; 2023; 19(5):1336-1351. PubMed ID: 37056930
[TBL] [Abstract][Full Text] [Related]
19. Cyclophilin A enhances cell proliferation and tumor growth of liver fluke-associated cholangiocarcinoma.
Obchoei S; Weakley SM; Wongkham S; Wongkham C; Sawanyawisuth K; Yao Q; Chen C
Mol Cancer; 2011 Aug; 10():102. PubMed ID: 21871105
[TBL] [Abstract][Full Text] [Related]
20. PGE2 signaling and its biosynthesis-related enzymes in cholangiocarcinoma progression.
Jongthawin J; Chusorn P; Techasen A; Loilome W; Boonmars T; Thanan R; Puapairoj A; Khuntikeo N; Tassaneeyakul W; Yongvanit P; Namwat N
Tumour Biol; 2014 Aug; 35(8):8051-64. PubMed ID: 24839005
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]